OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its 2023 Environmental, Social and Governance (ESG) report. This ESG report...
– Report Highlights Continued Progress on Patient Access, Health Equity, Diversity and Flexibility – – Aligns with the Sustainability Accounting Standards Board (SASB) Standards for the Biotechnology and Pharmaceuticals Industry...
The “Pharma and ESG – The Patient Perspective – The Views of 1,500 Patient Groups” report has been added to ResearchAndMarkets.com’s offering. This analysis of patient-group opinions on ESG is based on two online...
Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces strong year-on-year progress in its ESG...
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS),...